13-Amino-4,7,10-trioxatridecanyl-2,2',3,3',11,11',12,12'-d8)-N-methyl-N-biotinylglycinamide

• 产品号: A631852
• 分子式: C23H43N5O6S
• 分子量: 517.68242

产品别名

• 标题: 13-Amino-4,7,10-trioxatridecanyl-2,2',3,3',11,11',12,12'-d8)-N-methyl-N-biotinylglycinamide
• IUPAC标准名: 5-[(3aS,4S,6aR)-2-oxo-hexahydro-1H-thieno[3,4-d]imidazolidin-4-yl]-N-({[3-(2-{2-[3-amino(1,1,2,2-^2H₄)propoxy]ethoxy}ethoxy)(2,2,3,3-^2H₄)propyl]carbamoyl}methyl)-N-methylpentanamide
• IUPAC传统名: 5-[(3aS,4S,6aR)-2-oxo-hexahydrothieno[3,4-d]imidazolidin-4-yl]-N-({[3-(2-{2-[3-amino(1,1,2,2-^2H₄)propoxy]ethoxy}ethoxy)(2,2,3,3-^2H₄)propyl]carbamoyl}methyl)-N-methylpentanamide
• 别名: (3aS,4S,6aR)-N-(16-Amino-2-oxo-7,10,13-trioxa-3-azahexadec-1-yl)hexahydro-N-methyl-2-oxo-1H-thieno[3,4-d]imidazole-4-pentanamide

产品详细信息

详细说明 (English)

Streptavidin in antibody pretargeting: evaluation of methods for decreasing localization of Streptavidin to kidney while retaining its tumor binding capacity.

参考文献

• Hnatowich, D., et al.: J. Nucl. Med., 1987, 28, 1294, Sung, C., et al.: Cancer Res., 54, 2166 (1994)
• Hashmi, M., et al.: Drug Metab. Dispos., 23, 1362 (1994)
• Pimm, M., et al.: Nucl. Med. Commun., 9, 931 (1994)
• Alvarez-Diez, T., et al.: Nucl. Med. Biol.